RESTYLANE® 1 ml w/ Lidocaine

Where can I buy this product?

RESTYLANE® 1ml w/ Lidocaine (often referred to as Restylane-L) is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support. We are committed to ensuring all products are sourced and sold exclusively to qualified professionals.

Product Information

What is RESTYLANE® 1ml w/ Lidocaine (Restylane-L)?

RESTYLANE® 1ml w/ Lidocaine (Restylane-L) is a sterile, transparent gel of stabilized hyaluronic acid (HA) of non-animal origin, manufactured by Galderma. It utilizes the original and well-established NASHA® (Non-Animal Stabilized Hyaluronic Acid) technology. This technology creates a firmer HA gel with specific particle sizes, providing effective lift and volume.

This formulation contains 20mg/mL of stabilized hyaluronic acid and includes 0.3% lidocaine hydrochloride to enhance patient comfort during the injection procedure. It is indicated for mid-to-deep dermis injection for the correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and for injection into the lips for lip augmentation.

Storage: RESTYLANE® 1ml w/ Lidocaine should be stored up to 25°C (77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that all RESTYLANE® products are authentic, sourced through appropriate channels, and handled according to manufacturer specifications.

Note: For professional use only.

How does RESTYLANE® 1ml w/ Lidocaine (Restylane-L) work?

RESTYLANE® 1ml w/ Lidocaine leverages the NASHA® technology to provide a moderately firm HA gel that effectively adds volume upon injection. When placed in the mid-to-deep dermis, it physically lifts and fills moderate to severe wrinkles and folds, such as nasolabial folds and marionette lines, providing visible correction.

In the lips, its properties allow for noticeable volume enhancement and shaping. The NASHA® technology provides good structure and lift, making it a versatile option for various treatment goals. The HA component also contributes to tissue hydration.

Treatment results are visible immediately. The duration of effect for RESTYLANE® 1ml w/ Lidocaine typically lasts around 6 to 9 months for wrinkles and up to 6 months for lips, although individual results vary based on factors like patient metabolism, area treated, and volume injected. The integrated lidocaine significantly improves patient comfort during the procedure.

Indications for Use

RESTYLANE® 1ml w/ Lidocaine (Restylane-L) is indicated for adults (typically 21 years and older, consult local regulations/IFU) for:

• Correction of moderate to severe facial wrinkles and folds (e.g., nasolabial folds, marionette lines).
• Lip augmentation for increased volume and definition.

Appropriate patient selection, injection technique, and consideration of contraindications outlined in the Instructions for Use (IFU) are essential.

Primary Benefits

• Versatile filler suitable for moderate wrinkles/folds and lip augmentation.
• Utilizes established NASHA® technology for effective lift and structure.
• Provides immediate, visible correction and volume enhancement.
• Long history of clinical use and established safety profile.
• Contains lidocaine for improved patient comfort during injection.

Side Effects and Safety Information

Common side effects are typically mild to moderate, temporary, and related to the injection site, including:

• Swelling
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Lumps/Bumps (usually temporary)

Severe Adverse Events:
As with any dermal filler injection, there are risks of more serious complications. Practitioners must possess thorough anatomical knowledge and be prepared to manage complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to tissue necrosis (tissue death), scarring, or (in rare cases involving facial arteries) blindness or stroke. Prompt recognition and management according to established protocols are crucial.
• Severe allergic reactions (anaphylaxis)
• Inflammation, infection, or abscess formation
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals